![Suzanne Thornton-Jones](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Suzanne Thornton-Jones
Consigliere Generale presso GENPREX, INC.
Profilo
Suzanne Thornton-Jones is currently the Senior Vice President-Regulatory Affairs at Genprex, Inc. She previously worked as the VP-Regulatory Affairs & Project Team Lead at Affinia Therapeutics, Inc. and as the Vice President & Head-Regulatory Affairs at Tavanta Therapeutics, Inc. Dr. Thornton-Jones holds undergraduate, graduate, and doctorate degrees from Virginia Commonwealth University.
Posizioni attive di Suzanne Thornton-Jones
Società | Posizione | Inizio |
---|---|---|
GENPREX, INC. | Consigliere Generale | 22/08/2023 |
Precedenti posizioni note di Suzanne Thornton-Jones
Società | Posizione | Fine |
---|---|---|
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Consigliere Generale | - |
Tavanta Therapeutics, Inc.
![]() Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Consigliere Generale | - |
Formazione di Suzanne Thornton-Jones
Virginia Commonwealth University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GENPREX, INC. | Health Technology |
Aziende private | 2 |
---|---|
Tavanta Therapeutics, Inc.
![]() Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Health Technology |
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Suzanne Thornton-Jones